Approaches to the Individualized Management of MPNs: Best Practices and Guidance to Optimize Care

In this online CME-certified program centered around a dynamic CCO symposium in Orlando, experts discuss recent advances in the management of essential thrombocythemia, polycythemia vera, and myelofibrosis. Watch the on-demand Webcast and download the slides from the symposium and read expert commentaries on current and emerging therapeutic strategies for patients with MPNs.
Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD
Raajit K. Rampal, MD, PhD
Alessandro M. Vannucchi, MD
Srdan Verstovsek, MD, PhD

On-Demand Webcast

Watch this CME-certified on-demand Webcast of a CCO live symposium from ASH 2019 to gain insights from the experts on best practices for the individualized care of patients with myeloproliferative neoplasms.

Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD Raajit K. Rampal, MD, PhD Alessandro M. Vannucchi, MD
Physicians: maximum of 2.5 AMA PRA Category 1 Credits Released: January 17, 2020 Expiration: January 16, 2021

ClinicalThought

Outcomes are poor for patients with myelofibrosis who discontinue ruxolitinib due to loss of response or intolerance. In this commentary, I offer my thoughts on the best treatment options for these patients.

Srdan Verstovsek, MD, PhD Released: October 7, 2019

In this commentary, Raajit K. Rampal, MD, PhD, highlights key MPN studies that will be presented at the upcoming 2019 ASH annual meeting in Orlando.

Raajit K. Rampal, MD, PhD Released: December 2, 2019

Read expert answers to key questions from the audience at a recent symposium on optimal management of patients with myeloproliferative neoplasms.

Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD Raajit K. Rampal, MD, PhD Alessandro M. Vannucchi, MD
Released: January 16, 2020

Downloadable Slidesets

Download this slideset for expert perspectives on current best practices on diagnosis, driver mutations, and risk stratification for patients with MPNs.

Alessandro M. Vannucchi, MD Released: December 6, 2019

Download this slideset for expert perspectives on current best practices on managing patients with myelofibrosis.

Srdan Verstovsek, MD, PhD Released: December 6, 2019

Download this slideset for expert perspectives on emerging therapies and optimal management of patients with myelofibrosis that is intolerant/resistant to ruxolitinib.

Raajit K. Rampal, MD, PhD Released: December 6, 2019

Download this slideset for expert perspectives on best practice for managing patients with PV and ET.

Jean-Jacques Kiladjian, MD, PhD Released: December 6, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Celgene Corporation
CTI Biopharma
Geron

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?